Lab test

BIOLOGICAL2 trials

Sponsors

King's College London, University Hospital, Bordeaux

Conditions

Atrial Fibrillation (AF)HyperthyroidismNeuroendocrine TumorsThyroid CancerThyroid Carcinoma

Unknown Phase

Optimising Molecular Radionuclide Therapy

CompletedNCT04922801

King's College LondonHyperthyroidism, Neuroendocrine Tumors, Thyroid Cancer +1

Start: 2021-12-09End: 2022-11-05Updated: 2023-03-08

Identification of the Metabolic Signature of Atrial Fibrillation for Personalized Prevention

RecruitingNCT06735001

University Hospital, BordeauxAtrial Fibrillation (AF)

Start: 2025-03-10End: 2029-10-01Target: 400Updated: 2026-06-09